Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by nemo3on Dec 11, 2014 7:30pm
281 Views
Post# 23221767

RE:If rat results also destruct 100% of cancer cells ...

RE:If rat results also destruct 100% of cancer cells ...
I agree that an announcement stating that TLT's product worked in the rats would boost the stock up. I am cautiously optimistic on this stock and what it has for bladder cancer.  But we all know that we are far from claiming victory in that regard.  It also remains to be seen whether they can keep their timelines as they have missed them in the past.  I know they talked in 2013 of the human bladder trials happening in 2014 and we know that did not happen.  So we don't know what will happen in 2015 - will they meet their deadlines and if they do, is there success?

Hopefully the humandder cancer trials start in the first quarter of 2014 and of course - they work.  What is a given tho is that there are two outcomes here. One is that the effectiveness of this treatment does not work in humans and then the stock will tank. OR what we all want will happen and that is the treatment will be as successful with humans as it is on the rodents.  And if it does, then I think many here will be very wealthy.
Bullboard Posts